Related Experiment Video
Updated: May 12, 2026

09:04
Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
21.0K
Single-Cell Network Analysis Identifies CLEC4E as a Key Mediator of Proinflammatory mDC Responses in Influenza
Biorxiv : the Preprint Server for Biology
|September 5, 2025
Summary
Excessive immune responses drive influenza severity. Researchers identified CLEC4E in myeloid dendritic cells (mDCs) as a key driver, and inhibiting it reduced disease severity in mice.
Area of Science:
- Immunology
- Virology
- Computational Biology
Background:
- Influenza severity is often linked to the host's immune response, not just the virus.
- Understanding the molecular drivers of pro-inflammatory immune cells is crucial for treating severe influenza.
- Previous single-cell RNA sequencing studies identified immune cell populations but not their upstream regulators.
Purpose of the Study:
- To identify key molecular drivers of pro-inflammatory immune responses in influenza.
- To investigate the role of specific immune cells and their regulatory pathways in influenza pathogenesis.
- To uncover novel therapeutic targets for mitigating influenza-induced inflammation.
Main Methods:
- Integrated single-cell co-expression network analysis.
- Multi-layered key driver analysis to pinpoint regulatory molecules.
- Validation using independent patient datasets and in vivo murine models.
- Pharmacological inhibition of identified target genes.
Main Results:
- Myeloid dendritic cells (mDCs) were identified as central to the pro-inflammatory response during influenza infection.
- C-type lectin CLEC4E was pinpointed as a key upstream driver of pathological inflammation.
- CLEC4E's role was confirmed in human patient data and validated in vivo.
- Pharmacological inhibition of CLEC4E in mice significantly reduced influenza disease severity and viral load.
Conclusions:
- CLEC4E overexpression in mDCs contributes to pro-inflammatory signaling, exacerbating influenza severity.
- Single-cell network approaches are powerful for discovering novel therapeutic targets in complex immune responses.
- Targeting CLEC4E presents a promising therapeutic strategy for managing severe influenza.

